Literature DB >> 19618037

Pulmonary eosinophilia.

Luiz Eduardo Mendes Campos1, Luiz Fernando Ferreira Pereira.   

Abstract

Pulmonary eosinophilia comprises a heterogeneous group of diseases defined by eosinophilia in pulmonary infiltrates (bronchoalveolar lavage fluid) or in tissue (lung biopsy specimens). Although the inflammatory infiltrate is composed of macrophages, lymphocytes, neutrophils and eosinophils, eosinophilia is an important marker for the diagnosis and treatment. Clinical and radiological presentations can include simple pulmonary eosinophilia, chronic eosinophilic pneumonia, acute eosinophilic pneumonia, allergic bronchopulmonary aspergillosis and pulmonary eosinophilia associated with a systemic disease, such as in Churg-Strauss syndrome and hypereosinophilic syndrome. Asthma is frequently concomitant and can be a prerequisite, as in allergic bronchopulmonary aspergillosis and Churg-Strauss syndrome. In diseases with systemic involvement, the skin, the heart and the nervous system are the most affected organs. The radiological presentation can be typical, or at least suggestive, of one of three types of pulmonary eosinophilia: chronic eosinophilic pneumonia, acute eosinophilic pneumonia and allergic bronchopulmonary aspergillosis. The etiology of pulmonary eosinophilia can be either primary (idiopathic) or secondary, due to known causes, such as drugs, parasites, fungal infection, mycobacterial infection, irradiation and toxins. Pulmonary eosinophilia can be also associated with diffuse lung diseases, connective tissue diseases and neoplasia.

Entities:  

Mesh:

Year:  2009        PMID: 19618037     DOI: 10.1590/s1806-37132009000600010

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  17 in total

1.  Eosinophilic Lung Disease: Accompanied with 12 Cases.

Authors:  Tülin Sevim; Emine Aksoy; Fatma Tokgöz Akyıl; Meltem Çoban Ağca; Nilüfer Aykaç Kongar; Ferhan Özşeker
Journal:  Turk Thorac J       Date:  2015-10-01

2.  Peripheral blood eosinophilia in dogs: Prevalence and associated diseases.

Authors:  Abigail Guija-de-Arespacochaga; Loïc Kremer; Frank Künzel; Ilse Schwendenwein
Journal:  Vet Med Sci       Date:  2022-06-02

Review 3.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

Review 4.  Eosinophilic disorders in various diseases.

Authors:  Jocelyn Celestin; Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.919

5.  The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue.

Authors:  Alexandra Lind; Peter D Siersema; Johannes G Kusters; Jan A M Van der Linden; Edward F Knol; Leo Koenderman
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

6.  Hypereosinophilia Secondary to Disseminated Paracoccidioidomycosis.

Authors:  Mateo Mejia-Zuluaga; Samuel Rosas; Verónica Posada Vélez; Pedro A Quintero
Journal:  Am J Case Rep       Date:  2017-10-18

7.  Clinically suspected acute myopericarditis with cardiac tamponade associated with peripheral blood eosinophilia presenting in early pregnancy: a case report.

Authors:  Yu Kasamatsu; Takashi Kida; Mayumi Shigeru; Toru Tagashira; Naoki Murai; Eiji Takai; Hideyuki Takaoka
Journal:  J Med Case Rep       Date:  2013-05-13

8.  Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?

Authors:  Wolfgang Hohenforst-Schmidt; Andreas Riedel; Paul Zarogoulidis; Christian Franke; Andreas Gschwendtner; Haidong Huang; Nikolaos Machairiotis; Vasiliki Dramba; Konstantinos Zarogoulidis; Johnannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2012-12-10       Impact factor: 4.162

9.  Eosinophils in fungus-associated allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Front Pharmacol       Date:  2013-02-01       Impact factor: 5.810

Review 10.  Individual-level interventions to reduce personal exposure to outdoor air pollution and their effects on people with long-term respiratory conditions.

Authors:  Sadia Janjua; Pippa Powell; Richard Atkinson; Elizabeth Stovold; Rebecca Fortescue
Journal:  Cochrane Database Syst Rev       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.